… , impairment on QoL, complications of disease and therapy. Autoimmune Blistering Diseases
occurring in children can usually be managed with topical steroids with a good prognosis. …

… Eighty-nine percent of patients treated with rituximab and short-term prednisone were in
complete remission off therapy at 24 months, compared with 34% of patients treated with …

… sodium, and methotrexate) can be used in patients whose disease is not effectively controlled
with corticosteroids alone or when the use of corticosteroids is contraindicated. It may take …

… corticosteroids15, 21 and sometimes, a second-line therapy … The use of oral corticosteroids
was less frequent in our study … pemphigus after failure of local corticosteroid (90% of patients…

… Glucocorticoids are the mainstay of treatment for autoimmune blistering diseases (AIBDs).
The Glucocorticoid Toxicity Index (GTI) is a novel, outcome-based …

… initially improved after the patient contracted HIV, despite the need for high-dose systemic
corticosteroids for disease control prior to HIV infection. Clinical improvement was associated …

… the more rare blistering diseases, systemic corticosteroids, supportive and topical care, and
blistering diseases in children. The sections on systemic corticosteroids and supportive care …

… Rituximab and oral corticosteroid therapy are safe and effective when used as first-line
treatments for pemphigus patients, according to additional research. Cho and colleagues …

… Autoimmune blistering diseases (AIBD) are a group of rare yet potentially fatal disorders …
or non-extensive bullous pemphigoid, high potency topical steroids instead of oral …

… Glucocorticoids and adjuvant immunosuppressive drugs have been of major benefit for the
fast control of most of these disorders, but their long-term use … autoimmune bullous disorders, …